PsyPal is a randomised controlled trial across four countries that will investigate whether psilocybin therapy can help ease psychological and existential distress in patients suffering from four progressive diseases. PsyPal is funded by the European Union and Norrsken Mind is one of 19 partners in the project consortium.

The Swedish Network for Psychedelic Science (NPV) is a non-profit member association with the purpose of promoting research on psychedelics. The association has over 1000 members and organizes lectures and seminars related to psychedelic science.

PAREA is a non-profit, multistakeholder and multidisciplinary partnership, and Norrsken Mind is one of its Founding Members. By combining and streamlining the knowledge and expertise of its members, PAREA brings comprehensive advice and guidance to EU policymakers – whilst delivering value to society in the process.

Usona Institute is a 501(c)(3) non-profit medical research organization based in Madison, Wisconsin. Usona is dedicated to supporting and conducting pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin and other psychedelics. Norrsken Mind is collaborating with Usona to provide qualified researchers with pharmaceutical-grade psilocybin.

Blossom is a platform dedicated to making psychedelic science accessible, offering comprehensive databases, reports and insights on the latest developments in the psychedelic field.

HumanKindLabs catalyses psychedelic clinical research on set & setting and brings optimised treatment protocols into society. HumanKindLabs offers advisory services to researchers seeking to procure GMP grade psychedelic compounds for clinical trials.